AMIORG

Ami Organics Share Price

₹2,381.45 -49.1 (-2.02%)

26 Mar, 2025 21:02

SIP TrendupStart SIP in AMIORG

Start SIP

Performance

  • Low
  • ₹2,371
  • High
  • ₹2,467
  • 52 Week Low
  • ₹1,008
  • 52 Week High
  • ₹2,644
  • Open Price₹2,431
  • Previous Close₹2,431
  • Volume135,757

Investment Returns

  • Over 1 Month + 4%
  • Over 3 Month + 3.57%
  • Over 6 Month + 43.5%
  • Over 1 Year + 111.01%
SIP Lightning

Smart Investing Starts Here Start SIP with Ami Organics for Steady Growth!

Invest Now

Ami Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 80.3
  • PEG Ratio
  • 0.4
  • Market Cap Cr
  • 9,748
  • P/B Ratio
  • 8.1
  • Average True Range
  • 123.86
  • EPS
  • 29.71
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 23.21
  • RSI
  • 54.06
  • MFI
  • 72.21

Ami Organics Financials

Ami Organics Technicals

EMA & SMA

Current Price
₹2,381.45
-49.1 (-2.02%)
pointer
  • stock-down_img
  • Bearish Moving Average 2
  • stock-up_img
  • Bullish Moving Average 14
  • 20 Day
  • ₹2,334.56
  • 50 Day
  • ₹2,271.08
  • 100 Day
  • ₹2,141.27
  • 200 Day
  • ₹1,905.29

Resistance and Support

2406.5 Pivot Speed
  • R3 2,539.25
  • R2 2,503.35
  • R1 2,442.40
  • S1 2,345.55
  • S2 2,309.65
  • S3 2,248.70

What's your outlook on Ami Organics?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ami Organics Ltd. is a leading manufacturer of specialty chemicals and pharmaceutical intermediates, serving global pharmaceutical companies. With advanced R&D and manufacturing facilities, it focuses on developing high-quality, innovative solutions for diverse therapeutic areas.

Ami Organics has an operating revenue of Rs. 923.35 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 11% is healthy, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 17%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 38% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 93 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 61 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of A is the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ami Organics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-21 Stock Split
2025-01-28 Quarterly Results
2024-10-29 Quarterly Results
2024-08-12 Quarterly Results
2024-05-10 Audited Results & Final Dividend
Date Purpose Remarks
2024-09-13 FINAL Rs.3.00 per share(30%)Final Dividend
2023-09-18 FINAL Rs.3.00 per share(30%)Final Dividend
2022-08-01 FINAL Rs.3.00 per share(30%)Final Dividend
View More

Ami Organics F&O

Ami Organics Shareholding Pattern

35.96%
13.68%
4%
15.52%
23.56%
7.28%

About Ami Organics

  • NSE Symbol
  • AMIORG
  • BSE Symbol
  • 543349
  • ISIN
  • INE00FF01017

Similar Stocks to Ami Organics

Ami Organics FAQs

Ami Organics share price is ₹2,381 As on 26 March, 2025 | 20:48

The Market Cap of Ami Organics is ₹9748.3 Cr As on 26 March, 2025 | 20:48

The P/E ratio of Ami Organics is 80.3 As on 26 March, 2025 | 20:48

The PB ratio of Ami Organics is 8.1 As on 26 March, 2025 | 20:48

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23